Christopher Naughton
Keine laufenden Positionen mehr
Profil
Christopher Naughton has been a Director of Glycotex, Inc. since 1999, Chairman since September 2005 and President and Chief Executive Officer since October 2005.
He was President of Glycotex, Inc. from May 1999 to September 2005.
He has been a Director, President and Chief Executive Officer of Marshall Edwards, Inc. since 2000.
He has been Managing Director of Novogen since March 1997.
He received an undergraduate degree from Australian National University and the University of New South Wales.
Ehemalige bekannte Positionen von Christopher Naughton
| Unternehmen | Position | Ende |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Präsident | 01.12.2009 |
| MEI PHARMA, INC. | Präsident | 01.12.2009 |
Glycotex, Inc.
 Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Vorsitzender | - |
Ausbildung von Christopher Naughton
| The University of New South Wales | Graduate Degree |
| Australian National University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Health Technology |
